Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

T2 Biosystems CS (TTOO)

T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024

TTOO : 0.5800 (-18.50%)
What to Expect From Cardinal Health's Q1 2025 Earnings Report

Cardinal Health is expected to release its fiscal first-quarter earnings next month, and analysts project a single-digit profit decline.

XLV : 150.18 (+0.72%)
$SPX : 5,995.54 (+0.38%)
TTOO : 0.5800 (-18.50%)
CAH : 120.56 (+1.98%)
T2 Biosystems to Host Business Update Call on October 10, 2024

TTOO : 0.5800 (-18.50%)
T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

TTOO : 0.5800 (-18.50%)
T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens

TTOO : 0.5800 (-18.50%)
CAH : 120.56 (+1.98%)
T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results

TTOO : 0.5800 (-18.50%)
T2 Biosystems: Q2 Earnings Snapshot

T2 Biosystems: Q2 Earnings Snapshot

TTOO : 0.5800 (-18.50%)
T2 Biosystems: Q1 Earnings Snapshot

T2 Biosystems: Q1 Earnings Snapshot

TTOO : 0.5800 (-18.50%)
T2 Biosystems: Q3 Earnings Snapshot

T2 Biosystems: Q3 Earnings Snapshot

TTOO : 0.5800 (-18.50%)
Why Shares of T2 Biosystems Are Falling Friday

A revenue drop and a reverse stock split worried investors.

TTOO : 0.5800 (-18.50%)

Barchart Exclusives

3 Best Dividend-growth Stocks Soon To Be Crowned Kings
These three quality companies represent an excellent opportunity for long-term income generation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar